Keiichi Nakahara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Keiichi Nakahara has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Yukio Ando
Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan
7 shared publications - Shunya Nakane
Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
6 shared publications - Mitsuharu Ueda
Department of Neurology, Graduate School of Medical Sciences, Kumamoto University
5 shared publications Yukio Ando
Department of Neurology Graduate School of Medical Sciences Kumamoto University Kumamoto Japan
5 shared publicationsHidenori Matsuo
Department of Neurology National Hospital Organization Nagasaki Kawatana Medical Center Nagasaki Japan
4 shared publications- Satoshi Yamashita
Department of Neurology International University of Health and Welfare Narita Hospital Narita Japan
4 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152
Plantar-predominant sudomotor dysfunction in multiple system atrophy: a Sudoscan and 123I-MIBG myocardial scintigraphy study
- 29 September 2026
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152
Open AccessPlantar-predominant sudomotor dysfunction in multiple system atrophy: a Sudoscan and 123I-MIBG myocardial scintigraphy study
- 3 July 2026
- Published by Wiley in Neuropathology
- Vol. 46 (4) , e70068
Japanese Encephalitis With a Characteristic Neuropathological Distribution Following Early MRI ‐Based Diagnosis: An Autopsy Case
Japanese encephalitis (JE) is a mosquito‐borne viral infection of the central nervous system for which no specific antiviral treatment is available. We report the case of a 79‐year‐old man residing in Kumamoto Prefecture, southwestern Japan, with JE who presented with fever, impaired consciousness, and respiratory failure, and subsequently died of multiple organ failure despite early supportive care. Magnetic resonance imaging (MRI) revealed characteristic bilateral thalamic lesions, leading to an early clinical suspicion of JE before serological confirmation. Neuropathological findings, particularly, the involvement of the thalamus, substantia nigra, hippocampus, and anterior horn of the spinal cord, were consistent with previously reported cases of JE, while also demonstrating a broader distribution of lesions than suggested by antemortem MRI. As most cases of JE occur in unvaccinated individuals, vaccination should be considered in middle‐aged and older adults, particularly, those with low antibody titers against the JE virus.
- 3 July 2026
- Published by Wiley in Neuropathology
- Vol. 46 (4) , e70068
Japanese Encephalitis With a Characteristic Neuropathological Distribution Following Early MRI ‐Based Diagnosis: An Autopsy Case
Japanese encephalitis (JE) is a mosquito‐borne viral infection of the central nervous system for which no specific antiviral treatment is available. We report the case of a 79‐year‐old man residing in Kumamoto Prefecture, southwestern Japan, with JE who presented with fever, impaired consciousness, and respiratory failure, and subsequently died of multiple organ failure despite early supportive care. Magnetic resonance imaging (MRI) revealed characteristic bilateral thalamic lesions, leading to an early clinical suspicion of JE before serological confirmation. Neuropathological findings, particularly, the involvement of the thalamus, substantia nigra, hippocampus, and anterior horn of the spinal cord, were consistent with previously reported cases of JE, while also demonstrating a broader distribution of lesions than suggested by antemortem MRI. As most cases of JE occur in unvaccinated individuals, vaccination should be considered in middle‐aged and older adults, particularly, those with low antibody titers against the JE virus.
- 23 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (6) , e214099
Unmasking Cerebrotendinous Xanthomatosis
- 23 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (6) , e214099
Unmasking Cerebrotendinous Xanthomatosis
- Open Access
- 23 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77890
A Case of Multiple Intracranial Hemorrhages Due to Biopsy-Proven Varicella Zoster Virus Vasculopathy Without Rash
Varicella zoster virus (VZV) vasculopathy is a rare complication of VZV infection that can lead to severe neurological manifestations, including multiple intracranial hemorrhages. We report the case of an 80-year-old male patient with a history of Parkinson’s disease and hypertension who presented with altered consciousness and motor difficulties. Imaging studies revealed recurrent cortical-subcortical hemorrhages in the right frontal lobe. Laboratory tests showed elevated cerebrospinal fluid (CSF) protein, increased CSF cell count, and a significantly elevated VZV IgG antibody index, while CSF VZV DNA was undetectable. A brain biopsy confirmed the diagnosis, showing vasculitis with VZV DNA positivity via real-time polymerase chain reaction (PCR) and immunohistochemistry. The patient was treated with intravenous acyclovir and corticosteroids, which partially improved clinical outcomes. This case highlights the importance of considering VZV vasculopathy as a differential diagnosis in unexplained intracranial hemorrhages, even in the absence of typical skin lesions. Comprehensive diagnostic evaluation, including CSF antibody testing and brain biopsy, is essential for accurate diagnosis and management.
- 23 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77890
Open AccessA Case of Multiple Intracranial Hemorrhages Due to Biopsy-Proven Varicella Zoster Virus Vasculopathy Without Rash
Varicella zoster virus (VZV) vasculopathy is a rare complication of VZV infection that can lead to severe neurological manifestations, including multiple intracranial hemorrhages. We report the case of an 80-year-old male patient with a history of Parkinson’s disease and hypertension who presented with altered consciousness and motor difficulties. Imaging studies revealed recurrent cortical-subcortical hemorrhages in the right frontal lobe. Laboratory tests showed elevated cerebrospinal fluid (CSF) protein, increased CSF cell count, and a significantly elevated VZV IgG antibody index, while CSF VZV DNA was undetectable. A brain biopsy confirmed the diagnosis, showing vasculitis with VZV DNA positivity via real-time polymerase chain reaction (PCR) and immunohistochemistry. The patient was treated with intravenous acyclovir and corticosteroids, which partially improved clinical outcomes. This case highlights the importance of considering VZV vasculopathy as a differential diagnosis in unexplained intracranial hemorrhages, even in the absence of typical skin lesions. Comprehensive diagnostic evaluation, including CSF antibody testing and brain biopsy, is essential for accurate diagnosis and management.
- Open Access
- 18 October 2022
- Published by Springer Nature in Cureus
- Vol. 14 (10) , e30415
Histopathological Features of Gerhardt Syndrome in a Patient With Multiple System Atrophy: An Autopsy Case Report
Multiple system atrophy (MSA) is a progressive neurodegenerative disease characterized by autonomic failure, parkinsonism, and cerebellar ataxia. Gerhardt syndrome, which is inspiratory dyspnea with laryngeal stridor associated with dysfunction of the vocal folds, is a frequent and fatal complication of MSA. A 59-year-old man with a six-year history of MSA presented with ataxia and dysarthria. He also had dyspnea and stridor, which had worsened in the last three months, and died from respiratory distress. Autopsy revealed neurogenic group atrophy of the posterior cricoarytenoid (PCA) muscle, which suggested that laryngeal nerve damage caused abductor vocal fold paralysis in addition to cerebellar and brainstem atrophy with glial cytoplasmic inclusions. Our histopathological findings suggest that Gerhardt syndrome may be associated with neurogenic atrophy of the laryngeal abductor muscle (PCA muscle) of the vocal folds.
- 18 October 2022
- Published by Springer Nature in Cureus
- Vol. 14 (10) , e30415
Open AccessHistopathological Features of Gerhardt Syndrome in a Patient With Multiple System Atrophy: An Autopsy Case Report
Multiple system atrophy (MSA) is a progressive neurodegenerative disease characterized by autonomic failure, parkinsonism, and cerebellar ataxia. Gerhardt syndrome, which is inspiratory dyspnea with laryngeal stridor associated with dysfunction of the vocal folds, is a frequent and fatal complication of MSA. A 59-year-old man with a six-year history of MSA presented with ataxia and dysarthria. He also had dyspnea and stridor, which had worsened in the last three months, and died from respiratory distress. Autopsy revealed neurogenic group atrophy of the posterior cricoarytenoid (PCA) muscle, which suggested that laryngeal nerve damage caused abductor vocal fold paralysis in addition to cerebellar and brainstem atrophy with glial cytoplasmic inclusions. Our histopathological findings suggest that Gerhardt syndrome may be associated with neurogenic atrophy of the laryngeal abductor muscle (PCA muscle) of the vocal folds.
- 7 May 2021
- Published by Wiley in European Journal of Neurology
- Vol. 28 (8) , 2574-2581
Very late onset neuromyelitis optica spectrum disorders
Background and purpose: Neuromyelitis optica spectrum disorder (NMOSD) often presents in the elderly with an insidious onset of symptoms and aggressive progression. There have been anecdotal cases of very late onset (VLO)‐NMOSD, but case series reports are rare. The aim of this retrospective study was to clarify the clinical features of VLO‐NMOSD.Methods: According to the age at onset, we classified patients with NMOSD into three subgroups: ≤49 years, early onset NMOSD (EO‐NMOSD); 50–69 years, late onset NMOSD (LO‐NMOSD); and ≥70 years, VLO‐NMOSD. We evaluated the clinical characteristics, magnetic resonance imaging (MRI) findings, laboratory data, and immunotherapies of the groups.Results: Overall, 12 men and 64 women with a median (interquartile range) age at onset and duration of disease of 42.0 (29.0–55.8) years and 70.0 (16.3–143.0) months, respectively, were included. Eight (11%) patients had VLO‐NMOSD, 22 (29%) had LO‐NMOSD, and 46 (61%) had EO‐NMOSD. Patients with EO‐NMOSD had a significantly longer interval between episodes as well as time between the first symptom and diagnosis of NMOSD than did those with VLO‐NMOSD and LO‐NMOSD (p = 0.046). Optic neuritis and nerve lesions on MRI were significantly less frequent in patients with VLO‐NMOSD than in those with LO‐NMOSD and EO‐NMOSD (p = 0.002 and p = 0.028, respectively). In contrast, patients with VLO‐NMOSD had higher nadir Expanded Disability Status Scale and Nurick scale scores and a significantly longer spinal lesion length than did those with LO‐NMOSD and EO‐NMOSD (p = 0.029, p = 0.049, and p = 0.032, respectively).Conclusions: Patients with VLO‐NMOSD tend to develop severe myelitis with long cord lesions but not optic neuritis.
- 7 May 2021
- Published by Wiley in European Journal of Neurology
- Vol. 28 (8) , 2574-2581
Very late onset neuromyelitis optica spectrum disorders
Background and purpose: Neuromyelitis optica spectrum disorder (NMOSD) often presents in the elderly with an insidious onset of symptoms and aggressive progression. There have been anecdotal cases of very late onset (VLO)‐NMOSD, but case series reports are rare. The aim of this retrospective study was to clarify the clinical features of VLO‐NMOSD.Methods: According to the age at onset, we classified patients with NMOSD into three subgroups: ≤49 years, early onset NMOSD (EO‐NMOSD); 50–69 years, late onset NMOSD (LO‐NMOSD); and ≥70 years, VLO‐NMOSD. We evaluated the clinical characteristics, magnetic resonance imaging (MRI) findings, laboratory data, and immunotherapies of the groups.Results: Overall, 12 men and 64 women with a median (interquartile range) age at onset and duration of disease of 42.0 (29.0–55.8) years and 70.0 (16.3–143.0) months, respectively, were included. Eight (11%) patients had VLO‐NMOSD, 22 (29%) had LO‐NMOSD, and 46 (61%) had EO‐NMOSD. Patients with EO‐NMOSD had a significantly longer interval between episodes as well as time between the first symptom and diagnosis of NMOSD than did those with VLO‐NMOSD and LO‐NMOSD (p = 0.046). Optic neuritis and nerve lesions on MRI were significantly less frequent in patients with VLO‐NMOSD than in those with LO‐NMOSD and EO‐NMOSD (p = 0.002 and p = 0.028, respectively). In contrast, patients with VLO‐NMOSD had higher nadir Expanded Disability Status Scale and Nurick scale scores and a significantly longer spinal lesion length than did those with LO‐NMOSD and EO‐NMOSD (p = 0.029, p = 0.049, and p = 0.032, respectively).Conclusions: Patients with VLO‐NMOSD tend to develop severe myelitis with long cord lesions but not optic neuritis.
- Open Access
- 23 February 2021
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 8 (4) , 790-799
gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan
Objective: Patients with acquired autonomic dysfunction may have antibodies specific to the ganglionic nicotinic acetylcholine receptor (gAChR). However, the clinical features of children and adolescents with acquired autonomic dysfunction (AAD) remain unclear. This study aimed to determine the clinical features of pediatric patients with acquired autonomic dysfunction.Methods: This study retrospectively examined a series of patients of AAD with serum gAChR antibodies who were referred to our laboratory for antibody testing between January 2012 and April 2019. The study included 200 patients (P = 0.002). In addition, upper GI dysfunction was more prevalent in children than in adults (P = 0.042). In particular, nausea and vomiting occurred in 60.0% of children with AAD and in 21.1% of adults (P < 0.001). The frequency of paralytic ileus was significantly higher in children with AAD (20.0%) relative to adults (6.3%) (P = 0.030). Regarding extra‐autonomic manifestations, encephalopathy was more frequent in children (15.0%) than in adults (1.1%) (P < 0.001).Interpretation: Pediatric AAD patients have their own clinical characteristics, and these features may be unique to children and adolescents.
- 23 February 2021
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 8 (4) , 790-799
Open AccessgAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan
Objective: Patients with acquired autonomic dysfunction may have antibodies specific to the ganglionic nicotinic acetylcholine receptor (gAChR). However, the clinical features of children and adolescents with acquired autonomic dysfunction (AAD) remain unclear. This study aimed to determine the clinical features of pediatric patients with acquired autonomic dysfunction.Methods: This study retrospectively examined a series of patients of AAD with serum gAChR antibodies who were referred to our laboratory for antibody testing between January 2012 and April 2019. The study included 200 patients (P = 0.002). In addition, upper GI dysfunction was more prevalent in children than in adults (P = 0.042). In particular, nausea and vomiting occurred in 60.0% of children with AAD and in 21.1% of adults (P < 0.001). The frequency of paralytic ileus was significantly higher in children with AAD (20.0%) relative to adults (6.3%) (P = 0.030). Regarding extra‐autonomic manifestations, encephalopathy was more frequent in children (15.0%) than in adults (1.1%) (P < 0.001).Interpretation: Pediatric AAD patients have their own clinical characteristics, and these features may be unique to children and adolescents.
- 8 January 2021
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 123 (1) , 231-232
Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain–Barré syndrome: a case report
- 8 January 2021
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 123 (1) , 231-232
Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain–Barré syndrome: a case report
- 1 November 2020
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 8 (6) , 385-389
Correlation between urinary incontinence and psychosis in patients with advanced-stage Parkinson's disease
- 1 November 2020
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 8 (6) , 385-389
Correlation between urinary incontinence and psychosis in patients with advanced-stage Parkinson's disease
- 1 March 2020
- Published by Elsevier in Journal of Autoimmunity
- Vol. 108, 102403
A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy
- 1 March 2020
- Published by Elsevier in Journal of Autoimmunity
- Vol. 108, 102403
A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy